Chinese authorities have approved an inhalable vaccine against COVID-19a world first, which boosted the listing of its Tianjin-based manufacturer on Monday.
the vaccine CanSino Biologicsto be used as an emergency booster dose, has received the green light from the country’s medical products administration, the company said in a statement posted to the Hong Kong stock market on Sunday.
After the announcement, the company’s share price shot up to 14% on the stock market on Monday and ended up closing with a rise of 7.1%.
The vaccine, which does not require an injection and is easier to store, will be administered nasally via a spray.
“The approval will have a positive impact on the company’s results if the vaccine is subsequently acquired and used by the relevant government agencies,” the statement said.
Scientists from various countries around the world, such as Cuba, Canada and the United States, are working on vaccines that can be administered through the nose, a route of entry for the coronavirus.
Since 2020, China has approved eight vaccines against COVID-19 developed locally but has not yet allowed foreign vaccines to be used on its territory.
I am a highly experienced and well-connected journalist, with a focus on healthcare news. I have worked for several major news outlets, and currently work as an author at 24 news recorder. My work has been featured in many prestigious publications, and I have a wide network of contacts in the healthcare industry. I am highly passionate about my work, and strive to provide accurate and timely information to my readers.